Provide you with the best solution for the use of raw materials
Inflammation is a localized response to cellular damage (eg, from infection or trauma), characterized by telangiectasia, leukocyte infiltration, elevated temperature, and often pain, and is a protection designed to control harmful agents and clear damaged tissue mechanism. Inflammatory markers refer to the indicators on which inflammatory diseases are judged in clinical diagnosis.
Procalcitonin (procalcitonin, PCT) is a glycoprotein composed of 116 amino acids, and is the precursor peptide of calcitonin (calcitonin, CT). Procalcitonin can exist in normal human serum in free form. Under normal circumstances, the serum PCT level in the human body is very low, mostly lower than 0.1ng/ml; the PCT increases physiologically within 2 days of birth, up to 21ng/ml; the plasma PCT value of long-term hemodialysis patients can reach 1.5ng/ml ml.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA103-3M | PCT Antibody | Detection/Capture-Rapid test/FIA/CLIA | Mouse Antibody |
| HA103-5M | PCT Antibody | Capture/Detection-Rapid test/FIA | Mouse Antibody |
| HA103-1M | PCT Antibody | Capture-CLIA | Mouse Antibody |
| HP103-1 | PCT Antigen | Quality Control-Rapid test/FIA/CLIA | E.coli |
C-reactive protein (CRP) is an acute phase response protein synthesized by hepatocytes when the body is subjected to inflammatory stimuli such as microbial invasion or tissue damage. CRP increases within hours of the onset of inflammation, peaks within 48 hours, and returns to normal levels as the lesions resolve and tissue, structure, and function recover. This response is not affected by radiotherapy, chemotherapy, and corticosteroid therapy. Therefore, the detection of CRP has a wide range of clinical applications, including the diagnosis and differential diagnosis of acute infectious diseases, the monitoring of postoperative infection, the observation of antibiotic efficacy, the detection of the course of disease, and the judgment of prognosis.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA106-11M | CRP Antibody | Detection-FIA | Mouse Antibody |
| HA106-7M | CRP Antibody | Capture-FIA | Mouse Antibody |
| HA106-6M | CRP Antibody | Capture-FIA | Mouse Antibody |
| HP106-3 | CRP Antigen | Quality Control-Rapid test/FIA/CLIA | E.coli |
Serum amyloid A (Human serum amyloid A protein, SAA) is an acute phase reaction protein, which belongs to the heterogeneous protein of the apolipoprotein family, with a molecular weight of about 12000. In the acute phase response, stimulated by IL-1, IL-6 and TNF, SAA is synthesized in the liver by activated macrophages and fibroblasts, which can be increased to 100-1000 times the initial concentration, but the half-life Short, only about 50 minutes.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA141-4MB | SAA Antibody | Detection-Rapid test | Mouse Antibody |
| HA141-2M | SAA Antibody | Detection-FIA | Mouse Antibody |
| HA141-1M | SAA Antibody | Capture-Rapid test/FIA | Mouse Antibody |
| HA141-3MB | SAA Antibody | Capture-Rapid test/FIA | Mouse Antibody |
IL-6 has a molecular weight of 26 kD and consists of 184 amino acids. IL-6 is a pleiotropic cytokine that regulates a variety of cellular functions, including cell proliferation, cell differentiation, immune defense mechanisms, and hematopoiesis.After infection and inflammation, IL-6 was first produced and the level increased rapidly, reaching a peak at 2h, and its elevated level was consistent with the severity of infection, and induced procalcitonin (PCT) and CRP at 2h of infection, respectively. and began to increase after 6h.
| Cat.No. | Product Name | Application-Platform | Product Description |
|---|---|---|---|
| HA122-2M | IL-6 Antibody | Detection-FIA | Mouse Antibody |
| HA122-2H | IL-6 Antibody | Detection-CLIA | Humanized Antibody |
| HA122-1M | IL-6 Antibody | Capture-FIA/CLIA | Mouse Antibody |
| HP122-1 | IL-6 Antigen | Quality Control-FIA/CLIA | E.coli, a.a.r. 2-185 |
